Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Abnormalities, Congenital

imatinib mesylate has been researched along with Abnormalities, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ault, P; Beran, M; Cortes, J; Faderl, S; Giles, F; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Rios, MB; Talpaz, M1
Ali, R; Ozcelik, T; Ozkalemkas, F; Ozkan, A; Ozkocaman, V1

Other Studies

2 other study(ies) available for imatinib mesylate and Abnormalities, Congenital

ArticleYear
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-01, Volume: 24, Issue:7

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents; Benzamides; Congenital Abnormalities; Disease Progression; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Medical Records; Metaphase; Philadelphia Chromosome; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrimidines; Retrospective Studies; Teratogens

2006
Imatinib and pregnancy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-10, Volume: 24, Issue:23

    Topics: Abortion, Spontaneous; Adult; Animals; Antineoplastic Agents; Benzamides; Congenital Abnormalities; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimesters; Protein-Tyrosine Kinases; Pyrimidines; Teratogens

2006